Duopharma Biotech Berhad - Laporan Laba Rugi (TTM)

Duopharma Biotech Berhad
MY ˙ KLSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Duopharma Biotech Berhad menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 574 570 578 590 628 639 659 685 690 697 711 697 689 705 697 748 788 814 883 887
Change (%) -0.64 1.36 2.10 6.45 1.81 3.05 3.99 0.76 0.94 2.09 -2.00 -1.12 2.25 -1.07 7.29 5.28 3.32 8.57 0.39
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 345 337 343 351 375 385 397 414 415 417 425 414 414 436 437 479 506 512 563 558
Change (%) -2.50 1.98 2.12 6.97 2.70 2.96 4.51 0.05 0.53 1.90 -2.62 -0.02 5.51 0.17 9.55 5.68 1.20 9.91 -0.83
% of Revenue 60.21 59.08 59.45 59.46 59.74 60.26 60.21 60.51 60.08 59.84 59.73 59.35 60.01 61.92 62.70 64.02 64.26 62.94 63.72 62.94
Gross Operating Profit 228 233 234 239 253 254 262 270 276 280 286 283 276 268 260 269 281 302 321 329
Change (%) 2.18 0.45 2.07 5.71 0.49 3.19 3.21 1.86 1.56 2.36 -1.08 -2.73 -2.64 -3.08 3.49 4.58 7.14 6.31 2.53
% of Revenue 39.79 40.92 40.55 40.54 40.26 39.74 39.79 39.49 39.92 40.16 40.27 40.65 39.99 38.08 37.30 35.98 35.74 37.06 36.28 37.06
SG&A 153 150 149 154 162 166 171 176 180 186 190 190 189 187 183 186 192 201 207 211
Change (%) -2.27 -0.44 3.10 4.93 2.69 3.03 2.97 2.17 3.51 2.32 -0.00 -0.75 -1.14 -2.06 1.69 3.06 4.60 3.20 1.85
% of Revenue 26.76 26.32 25.85 26.10 25.73 25.95 25.95 25.69 26.05 26.71 26.77 27.32 27.42 26.51 26.24 24.87 24.35 24.65 23.43 23.77
R&D
Change (%)
% of Revenue
OpEx 499 488 490 502 536 550 567 592 596 604 616 605 605 626 623 668 698 713 770 769
Change (%) -2.23 0.46 2.30 6.77 2.78 2.93 4.43 0.78 1.28 2.00 -1.81 0.04 3.48 -0.41 7.08 4.52 2.26 7.94 -0.09
% of Revenue 87.03 85.64 84.88 85.05 85.30 86.11 86.01 86.37 86.38 86.66 86.59 86.76 87.78 88.83 89.42 89.24 88.59 87.68 87.16 86.74
Operating Income 74 82 87 88 92 89 92 93 94 93 95 92 84 79 74 80 90 100 113 118
Change (%) 10.03 6.71 0.95 4.68 -3.84 3.81 1.32 0.69 -1.17 2.62 -3.20 -8.75 -6.54 -6.27 9.08 11.62 11.61 13.11 3.66
% of Revenue 12.97 14.36 15.12 14.95 14.70 13.89 13.99 13.63 13.62 13.34 13.41 13.24 12.22 11.17 10.58 10.76 11.41 12.32 12.84 13.26
Interest Expense -7 -7 -7 -6 -7 -6 -6 -6 -8 -9 -10 -12 -14 -18 -22 -24 -26 -26 -25 -25
Change (%) -2.28 0.51 -1.25 2.33 -2.84 -3.15 -0.14 29.37 12.95 10.24 20.97 16.13 25.47 25.07 10.07 5.38 0.48 -2.75 -2.03
% of Revenue -1.16 -1.14 -1.14 -1.10 -1.06 -1.01 -0.95 -0.91 -1.17 -1.31 -1.41 -1.74 -2.04 -2.51 -3.17 -3.25 -3.26 -3.17 -2.84 -2.77
Net Income 54 59 63 63 66 66 68 69 69 70 72 69 61 53 45 49 56 63 73 77
Change (%) 7.64 6.92 1.05 4.48 -0.72 4.08 1.35 -0.89 2.10 3.34 -5.21 -10.74 -14.12 -13.97 9.16 13.40 11.74 16.54 4.81
% of Revenue 9.49 10.28 10.85 10.74 10.54 10.28 10.38 10.11 9.95 10.06 10.19 9.85 8.90 7.47 6.50 6.61 7.12 7.70 8.26 8.63

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista